These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26908269)

  • 21. Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-gamma release assay.
    Torres Costa J; Sá R; Cardoso MJ; Silva R; Ferreira J; Ribeiro C; Miranda M; Plácido JL; Nienhaus A
    Eur Respir J; 2009 Dec; 34(6):1423-8. PubMed ID: 19948911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. False-positive quantiferon results at a large healthcare institution.
    Slater M; Dubose A; Banaei N
    Clin Infect Dis; 2014 Jun; 58(11):1641-2. PubMed ID: 24610428
    [No Abstract]   [Full Text] [Related]  

  • 23. The evidence for greater sensitivity of interferon-γ release assays compared to tuberculin skin test in diagnosing latent Mycobacterium tuberculosis infection.
    Eisenhut M
    Clin Pediatr (Phila); 2014 Dec; 53(14):1413. PubMed ID: 25169803
    [No Abstract]   [Full Text] [Related]  

  • 24. Tuberculosis in healthcare workers, Scotland.
    Pollock KG; McDonald E; Smith-Palmer A; Johnston F; Ahmed S
    Scott Med J; 2017 Aug; 62(3):101-103. PubMed ID: 28836925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brief report: number of tuberculosis tests and diagnoses of latent tuberculosis infection in active component service members, U.S. Armed Forces, January 2004-December 2014.
    Armed Forces Health Surveillance Center (AFHSC)
    MSMR; 2014 Dec; 21(12):8-10; discussion 9-10. PubMed ID: 25555209
    [No Abstract]   [Full Text] [Related]  

  • 26. Current approach to latent tuberculosis diagnosis and treatment among medical center occupational health physicians.
    Vinnard C; Linkin D; Behrman A
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1262-5. PubMed ID: 23143368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of cytotoxic and targeted antineoplastic drugs on the validity of the mitogen-induced interferon-gamma release assay for latent tuberculosis infection: results of a prospective trial at a comprehensive cancer center.
    Rodriguez GH; Safdar A
    Scand J Infect Dis; 2014 Jan; 46(1):52-7. PubMed ID: 24106983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of an interferon-gamma release assay to diagnose latent tuberculosis infection during pregnancy.
    Lighter-Fisher J; Surette AM
    Obstet Gynecol; 2012 Jun; 119(6):1088-95. PubMed ID: 22569120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
    Dorman SE; Belknap R; Graviss EA; Reves R; Schluger N; Weinfurter P; Wang Y; Cronin W; Hirsch-Moverman Y; Teeter LD; Parker M; Garrett DO; Daley CL;
    Am J Respir Crit Care Med; 2014 Jan; 189(1):77-87. PubMed ID: 24299555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of interferon-gamma release assay in tuberculosis control.
    Jurčev-Savičević A; Katalinić-Janković V; Miše K; Gudelj I
    Arh Hig Rada Toksikol; 2012 Mar; 63(1):49-59. PubMed ID: 22450206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection: an updated review.
    Moon HW; Hur M
    Ann Clin Lab Sci; 2013; 43(2):221-9. PubMed ID: 23694799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?
    Banaei N; Gaur RL; Pai M
    J Clin Microbiol; 2016 Apr; 54(4):845-50. PubMed ID: 26763969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-gamma release assays and the diagnosis of tuberculosis: have they found their place?
    Darby J; Black J; Buising K
    Intern Med J; 2014 Jul; 44(7):624-32. PubMed ID: 25041769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acceptability of interferon-gamma release assays among healthcare workers who receive routine employee tuberculosis testing.
    Hirsch-Moverman Y; Wall K; Weinfurter P; Munk E; Moran JA; Maiuris A; Khan A; DeLuca N;
    Int J Occup Environ Health; 2013; 19(4):319-24. PubMed ID: 24588038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness analysis of interferon-γ release assays versus chest X-ray for annual tuberculosis screening of healthcare workers.
    Kowada A; Deshpande GA; Takahashi O; Shimbo T; Fukui T
    J Hosp Infect; 2011 Jun; 78(2):152-4. PubMed ID: 21440954
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in the diagnosis of latent tuberculosis infection.
    Schluger NW
    Semin Respir Crit Care Med; 2013 Feb; 34(1):60-6. PubMed ID: 23460006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of routine interferon-gamma release assay testing in a South London HIV cohort.
    Sandhu P; Taylor C; Miller RF; Post FA
    Int J STD AIDS; 2020 Mar; 31(3):264-267. PubMed ID: 32036752
    [No Abstract]   [Full Text] [Related]  

  • 38. [Screening contacts for latent tuberculosis infection (LTBI) using an interferon test in Paris in 2009].
    Fournier A; Antoun F; Collignon A; Muller G; Rouvier J; Ayache B; Guesnon MS; Larnaudie S
    Rev Mal Respir; 2012 Jan; 29(1):28-39. PubMed ID: 22240217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. False-positive QuantiFERON TB-Gold test due to Mycobacterium gordonae.
    Gajurel K; Subramanian AK
    Diagn Microbiol Infect Dis; 2016 Apr; 84(4):315-7. PubMed ID: 26827092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberculosis screening in a dialysis unit: detecting latent tuberculosis infection is only half the problem.
    Brij SO; Beck SC; Kleemann F; Jack AL; Wilkinson C; Enoch DA
    J Hosp Infect; 2014 Aug; 87(4):241-4. PubMed ID: 25027226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.